Reduced 10-Year Risk of Coronary Heart Disease in Patients Who Participated in a Community-Based Diabetes Prevention Program
Open Access
- 1 March 2009
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 32 (3) , 394-396
- https://doi.org/10.2337/dc08-1622
Abstract
OBJECTIVE—We evaluated whether participation in a community-based group diabetes prevention program might lead to relative changes in composite 10-year coronary heart disease (CHD) risk for overweight adults with abnormal glucose metabolism. RESEARCH DESIGN AND METHODS—We used the UK Prospective Diabetes Study engine to estimate CHD risk for group-lifestyle and brief counseling (control) groups. Between-group risk changes after 4 and 12 months were compared using ANCOVA. RESULTS—Baseline 10-year risk was similar between treatment groups (P = 0.667). At 4 and 12 months, the intervention group experienced significant decreases in 10-year risk from baseline (−3.28%, P < 0.001; and −2.23%, P = 0.037) compared with control subjects (−0.78%, P = 0.339; and +1.88%, P = 0.073). Between-group differences were statistically significant and increased from the 4- to 12-month visits. CONCLUSIONS—Community-based delivery of the Diabetes Prevention Program lifestyle intervention could be a promising strategy to prevent both CHD and type 2 diabetes in adults with pre-diabetes.Keywords
This publication has 14 references indexed in Scilit:
- Translating the Diabetes Prevention Program into the CommunityAmerican Journal of Preventive Medicine, 2008
- From hyperglycemia to the risk of cardiovascular disease2006
- Impact of Intensive Lifestyle and Metformin Therapy on Cardiovascular Disease Risk Factors in the Diabetes Prevention ProgramDiabetes Care, 2005
- Pre-diabetes, insulin resistance, inflammation and CVD riskDiabetes Research and Clinical Practice, 2003
- Estimated Number of Adults With Prediabetes in the U.S. in 2000Diabetes Care, 2003
- Screening for Type 2 DiabetesDiabetes Care, 2003
- Accuracy and precision of the Cholestech LDX System in monitoring blood lipid levels.American Journal of Health-System Pharmacy, 2002
- The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56)Clinical Science, 2001
- Laboratory Evaluation of the DCA 2000 Clinic HbA1c Immunoassay AnalyserAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1994
- Immediate HbA1c Results: Performance of new HbA1c system in pediatric outpatient populationDiabetes Care, 1992